Trial uses your tumor’s immune cells for advanced solid cancers
Treatments studied
Part of Cancer clinical trials.
This early-phase trial tests whether collecting immune cells from your tumor (tumor infiltrating lymphocytes) is safe and can help treat advanced solid cancers. It may help by strengthening your body’s immune attack on the cancer after standard treatments are no longer working.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 75 years old when you sign consent
- Have one of these advanced cancers: non-small cell lung cancer, cervical cancer, or breast cancer (women only)
- Your cancer must have grown or stopped responding after first standard treatment, or there’s no good standard option left
- You must have at least one treatable tumor spot that can be measured and that hasn’t had radiation or other local treatment in the last 28 days
- Overall health must be good enough for treatment (ECOG 0–2 and expected survival > 3 months, with blood and organ tests within limits)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a treatment that uses your own immune cells, called TILs, to fight advanced solid tumors. The cells are taken from a biopsy of your tumor, multiplied in a lab, and then given back to you. It might help if you have tried other treatments without success, or if no standard treatment is available.
This trial tests an experimental cell therapy (HS-IT101) for people with advanced solid tumors that have not responded to standard treatments. It uses immune cells from your own tumor to fight cancer, and researchers want to see if it is safe and effective.
This trial tests a type of immune cell treatment called TIL (tumor-infiltrating lymphocytes) in people with advanced solid cancers. It may help your immune system better recognize and attack tumors, especially if standard treatments have not worked.
This early-phase study tests a treatment made from your own tumor-fighting immune cells (TIL cells) for advanced solid cancers that have worsened or no longer respond to standard therapy. The main goal is to learn whether it is safe and whether it can shrink tumors for people who have limited options.
This study tests a new treatment that uses your own immune cells, called TIL, to fight advanced solid tumors. It may be given alone or with another drug that helps the immune system attack cancer. The goal is to see if this treatment is safe and effective for people who have already tried other treatments.
This trial tests a treatment that takes immune cells from your tumor, multiplies them in a lab, and gives them back to you to fight the cancer. It is for people with advanced solid tumors who have tried other treatments or cannot have them.
Hear when a new Advanced Solid Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.